BAUMAL CAROLINE (Chief Medical Officer) sold 3.1% of their position (2.80K shares) of APELLIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $60.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/23/2026ACC: 0001492422-26-000061
Officer· Chief Medical Officer
Since Jan 2023
-2.80K
Net shares
Net seller
$60.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.80K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.80K
Price / share
$21.77
Trade value
$60.88K
% of position
3.1%
1/22/2026
89.32K→86.53K
Total
Net shares
−2.80K
Net value
-$60.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/22/2026 | S · Sale | −2.80K | $21.77 | $60.88K | 3.1% | 89.32K | 86.53K |
| Total | −2.80K | -$60.88K | ||||||
Derivative Transactions0
No derivative transactions reported